Answers are grounded in this paper and cite their sources.
Compares the effects of estradiol and daidzein on endometrial cancer-related genes in ovariectomized rats, suggesting a safer management approach.
DZD demonstrated a potentially beneficial effect by improving uterine anti-oxidant capacity and preventing atrophy, but without the hyperplastic changes associated with estradiol. These findings suggest that DZD may be a safer alternative for managing hypoestrogenic conditions, warranting further investigation.
No takes yet. Share an insight, caveat, or question.
Setayesh et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: